×

Investors seem comfortable with gridlock in Congress: Cowen's Eric Schmidt

1:06 PM ET Tue, 25 July 2017

Eric Schmidt, biotech analyst at Cowen and Co., discusses whether the Congressional Democrats "better plan" agenda will impact the biotech market.